Literature DB >> 362187

Granuloma pouch assay. I. Induction of ouabain resistance by MNNG in vivo.

P Maier, P Manser, G Zbinden.   

Abstract

Growth of granulation tissue was induced in rats inside a subcutaneous air pouch by injection of croton oil. Granulation tissue, isolated and cultured in vitro, gave satisfactory and reproducible cloning efficiency of fibroblast-like cells. This experimental model system was used to study the induction of autosomal point mutations in vivo leading to ouabain resistance. For this purpose the mutagen MNNG was administered in the granuloma pouch, and the formation of ouabain-resistant clones was determined in vitro. Various application schedules, expression times in vivo and selective conditions in vitro were evaluated. The highest frequencies of ouabain-resistant clones were found when MNNG was injected into the pouch 24--48 h after induction of granulation tissue, followed by an expression time in vivo of 24--48 h. No ouabain-resistant clones were formed by cells isolated from untreated rats or from animals receiving the highest tolerated doses of MNNG per os or by intraperitoneal injection. The potential usefulness of the granuloma pouch assay for the evaluation of mutagenic and carcinogenic substances in vivo is discussed.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 362187     DOI: 10.1016/0165-1161(78)90036-5

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  3 in total

1.  Granuloma pouch assay for mutagenicity testing.

Authors:  P Maier
Journal:  Arch Toxicol       Date:  1980-11       Impact factor: 5.153

2.  Granuloma pouch assay. III. Enhancement of the carcinogenic effect of N-methyl-N'-nitro-N-nitrosoguanidine.

Authors:  G Zbinden; P Maier; S Alder
Journal:  Arch Toxicol       Date:  1980-09       Impact factor: 5.153

3.  Comparative studies on the covalent binding of the carcinogen benzo(a)pyrene to DNA in various model systems.

Authors:  W Jaggi; W K Lutz; C Schlatter
Journal:  Experientia       Date:  1979-05-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.